BlackRock Inc. cut its position in shares of PAREXEL International Corporation (NASDAQ:PRXL) by 1.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,432,566 shares of the medical research company’s stock after selling 80,890 shares during the quarter. BlackRock Inc. owned approximately 10.70% of PAREXEL International Corporation worth $472,144,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. World Asset Management Inc grew its holdings in shares of PAREXEL International Corporation by 0.3% during the second quarter. World Asset Management Inc now owns 3,212 shares of the medical research company’s stock worth $279,000 after buying an additional 9 shares in the last quarter. Public Employees Retirement System of Ohio grew its holdings in shares of PAREXEL International Corporation by 4.5% during the first quarter. Public Employees Retirement System of Ohio now owns 1,713 shares of the medical research company’s stock worth $108,000 after buying an additional 73 shares in the last quarter. Meadow Creek Investment Management LLC grew its holdings in shares of PAREXEL International Corporation by 7.1% during the first quarter. Meadow Creek Investment Management LLC now owns 1,980 shares of the medical research company’s stock worth $125,000 after buying an additional 132 shares in the last quarter. Baird Financial Group Inc. grew its holdings in shares of PAREXEL International Corporation by 2.3% during the first quarter. Baird Financial Group Inc. now owns 5,812 shares of the medical research company’s stock worth $367,000 after buying an additional 133 shares in the last quarter. Finally, Texas Permanent School Fund grew its holdings in shares of PAREXEL International Corporation by 0.5% during the second quarter. Texas Permanent School Fund now owns 37,062 shares of the medical research company’s stock worth $3,221,000 after buying an additional 169 shares in the last quarter. Institutional investors and hedge funds own 87.45% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “BlackRock Inc. Sells 80,890 Shares of PAREXEL International Corporation (PRXL)” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.dailypolitical.com/2017/09/25/blackrock-inc-sells-80890-shares-of-parexel-international-corporation-prxl.html.

PRXL has been the subject of a number of recent research reports. BidaskClub downgraded shares of PAREXEL International Corporation from a “strong-buy” rating to a “buy” rating in a report on Friday, July 28th. Mizuho boosted their target price on shares of PAREXEL International Corporation from $66.00 to $75.00 and gave the company a “buy” rating in a report on Tuesday, May 30th. Zacks Investment Research upgraded shares of PAREXEL International Corporation from a “hold” rating to a “buy” rating and set a $98.00 target price for the company in a report on Tuesday, August 8th. Jefferies Group LLC restated a “hold” rating and issued a $88.10 target price on shares of PAREXEL International Corporation in a report on Wednesday, June 21st. Finally, Raymond James Financial, Inc. upgraded shares of PAREXEL International Corporation from an “underperform” rating to a “mkt perform” rating in a report on Tuesday, June 20th. Two research analysts have rated the stock with a sell rating, nine have assigned a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $75.92.

Shares of PAREXEL International Corporation (NASDAQ:PRXL) opened at 87.99 on Monday. The stock has a market capitalization of $4.50 billion, a P/E ratio of 42.71 and a beta of 0.79. The company has a 50-day moving average of $87.74 and a 200-day moving average of $78.14. PAREXEL International Corporation has a 12-month low of $51.16 and a 12-month high of $88.07.

PAREXEL International Corporation (NASDAQ:PRXL) last issued its earnings results on Monday, August 28th. The medical research company reported $1.02 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.08. The company had revenue of $557.20 million for the quarter, compared to the consensus estimate of $537.59 million. PAREXEL International Corporation had a return on equity of 28.98% and a net margin of 4.49%. During the same quarter in the prior year, the company earned $0.94 EPS. Equities analysts expect that PAREXEL International Corporation will post $3.95 earnings per share for the current fiscal year.

PAREXEL International Corporation Company Profile

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries.

Institutional Ownership by Quarter for PAREXEL International Corporation (NASDAQ:PRXL)

Receive News & Ratings for PAREXEL International Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAREXEL International Corporation and related companies with MarketBeat.com's FREE daily email newsletter.